Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.
Clinical trial NCT05182125 · COMPLETED
Trial details
- NCT number
- NCT05182125
- Sponsor
- HIV Vaccine Trials Network
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-25
- Primary completion
- 2023-08-21
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.